Fig. 3From: Chronic administration of AMD3100 increases survival and alleviates pathology in SOD1G93A mice model of ALSIncrease in the number of motor neurons in lamina X following AMD3100 treatment. SOD1G93A mice were treated with AMD3100 (n = 3) or PBS (n = 3) starting at 50 days old and sacrificed at 110 days old. Fifteen nonadjacent sections per group of lumbar spinal cords were stained with thionin and analyzed within the lamina X zone of central canal. Results are mean ± S.E.M., *p < 0.05Back to article page